BIOCRYST PHARMACEUTICALS, INC.
EPS
| Fiscal Year | EPS | Cyclically Adjusted EPS |
|---|---|---|
| FY2019 | $-940.00 | $-116.28 |
| FY2020 | $-1.09 | $-116.30 |
| FY2021 | $-1.03 | $-116.24 |
| FY2022 | $-1.33 | $-116.28 |
| FY2023 | $-1.18 | $-116.33 |
EPS
| Fiscal Year | EPS | Cyclically Adjusted EPS |
|---|---|---|
| FY2019 | $-940.00 | $-116.28 |
| FY2020 | $-1.09 | $-116.30 |
| FY2021 | $-1.03 | $-116.24 |
| FY2022 | $-1.33 | $-116.28 |
| FY2023 | $-1.18 | $-116.33 |